Back
Plus Therapeutics Vs. Y-mAbs Therapeutics Industry Stock Comparison
Sell
32
PSTV
Plus Therapeutics
Last Price:
1.69
Seasonality Move:
-9.33%
Sell
50
YMAB
Y-mAbs Therapeutics
Last Price:
14.99
Seasonality Move:
16.54%
Sell
32
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy, Sell or Hold?
- The current Plus Therapeutics [PSTV] share price is $1.69. The Score for PSTV is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- PSTV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Y-mAbs Therapeutics (YMAB)
is a Sell
Is Y-mAbs Therapeutics a Buy, Sell or Hold?
- The current Y-mAbs Therapeutics [YMAB] share price is $14.97. The Score for YMAB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- YMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PSTV Stock Price Chart
What is Plus Therapeutics's stock price today?
-
The Plus Therapeutics share price today is $1.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing selling pressure, which indicates risk of future bearish movement.
YMAB Stock Price Chart
What is Y-mAbs Therapeutics's stock price today?
-
The Y-mAbs Therapeutics share price today is $14.97
The current trend is relatively stagnant and YMAB is experiencing slight selling pressure.
PSTV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 38.58 | Sell |
| Chaikin Money Flow: | -6191 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.75 - 1.89) | Sell |
| Bollinger Bands (100): | (1.77 - 2.05) | Sell |
YMAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 49.34 | Sell |
| Chaikin Money Flow: | -175949 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.25 - 15.91) | Sell |
| Bollinger Bands (100): | (7.74 - 16.08) | Buy |
PSTV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.8 | Sell |
| 20-day SMA: | 1.84 | Sell |
| 50-day SMA: | 1.87 | Sell |
| 200-day SMA: | 1.89 | Sell |
| 8-day EMA: | 1.78 | Sell |
| 20-day EMA: | 1.82 | Sell |
| 50-day EMA: | 1.85 | Sell |
| 200-day EMA: | 2.4 | Sell |
YMAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.63 | Buy |
| 20-day SMA: | 15.16 | Sell |
| 50-day SMA: | 15.6 | Sell |
| 200-day SMA: | 8.76 | Buy |
| 8-day EMA: | 14.85 | Buy |
| 20-day EMA: | 15.01 | Sell |
| 50-day EMA: | 14.51 | Buy |
| 200-day EMA: | 10.51 | Buy |
Plus Therapeutics Earnings Growth & PSTV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.04 per share, an increase this year of $2.58 per share, and an increase next year of $0.41 per share.
Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.25 per share.
Plus Therapeutics Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Y-mAbs Therapeutics Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||